{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:55:37Z","timestamp":1792032937481,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.canlet.2024.217058","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T16:46:07Z","timestamp":1718383567000},"page":"217058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK\/T cell lymphoma growth"],"prefix":"10.1016","volume":"597","author":[{"given":"Shaojie","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qisi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.217058_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume":"10","author":"Tse","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2024.217058_bib2","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","article-title":"NK-\/T-cell lymphomas","volume":"35","author":"Wang","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2024.217058_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.4459","article-title":"The Epstein-Barr virus and the pathogenesis of lymphoma","volume":"235","author":"Vockerodt","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2024.217058_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.217058_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2020.08.025","article-title":"The epigenetic roles of DNA N6-Methyladenine (6mA) modification in eukaryotes","volume":"494","author":"Wu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217058_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrg3724","article-title":"Gene expression regulation mediated through reversible m super(6)A RNA methylation","volume":"15","author":"Fu","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2024.217058_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2017.08.030","article-title":"Roles of RNA methylation by means of N(6)-methyladenosine (m(6)A) in human cancers","volume":"408","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217058_bib8","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","article-title":"RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming","volume":"12","author":"Yin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217058_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2021.04.020","article-title":"METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma","volume":"511","author":"Chang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217058_bib10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","article-title":"R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m(6)A\/PFKP\/LDHB axis","volume":"81","author":"Qing","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2024.217058_bib11","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1016\/j.molcel.2023.10.025","article-title":"EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma","volume":"83","author":"Lv","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2024.217058_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216613","article-title":"N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the mir-128-3p\/MAPK1 axis","volume":"585","author":"Yi","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217058_bib13","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41375-023-01904-1","article-title":"HIF1\u03b1-mediated transactivation of WTAP promotes AML cell proliferation via m6A-dependent stabilization of KDM4B mRNA","volume":"37","author":"Shao","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2024.217058_bib14","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.2019003764","article-title":"piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL","volume":"137","author":"Han","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.217058_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nprot.2012.148","article-title":"Transcriptome-wide mapping of N(6)-methyladenosine by m(6)A-seq based on immunocapturing and massively parallel sequencing","volume":"8","author":"Dominissini","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2024.217058_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature14281","article-title":"N6-methyladenosine marks primary microRNAs for processing","volume":"519","author":"Alarcon","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.217058_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and Transcriptomic characterization of natural killer T cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2024.217058_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein-Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.canlet.2024.217058_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/v15020423","article-title":"Comprehensive profiling of EBV gene expression and promoter methylation reveals latency II viral infection and sporadic abortive lytic activation in peripheral T-cell lymphomas","volume":"15","author":"Ho","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.canlet.2024.217058_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-023-01477-7","article-title":"Methyltransferase-like proteins in cancer biology and potential therapeutic targeting","volume":"16","author":"Qi","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2024.217058_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","article-title":"The roles and implications of RNA m6A modification in cancer","volume":"20","author":"Deng","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.217058_bib22","doi-asserted-by":"crossref","first-page":"e1279","DOI":"10.1002\/ctm2.1279","article-title":"RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A\u2010YTHDF2\u2010dependent manner","volume":"13","author":"Shen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2024.217058_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13045-023-01416-6","article-title":"Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis","volume":"16","author":"Jin","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2024.217058_bib24","first-page":"627","volume":"34","author":"Li","year":"2023"},{"key":"10.1016\/j.canlet.2024.217058_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/iub.2410","article-title":"m6A methyltransferase Wilms' tumor 1\u2010associated protein facilitates cell proliferation and cisplatin resistance in NK\/T cell lymphoma by regulating dual\u2010specificity phosphatases 6 expression via m6A RNA methylation","volume":"73","author":"Ma","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.canlet.2024.217058_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fimmu.2020.00367","article-title":"Role of viral and host microRNAs in immune regulation of epstein-barr virus-associated diseases","volume":"11","author":"Iizasa","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.217058_bib27","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s11033-021-06152-z","article-title":"A review on EBV encoded and EBV-induced host microRNAs expression profile in different lymphoma types","volume":"48","author":"Soltani","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.canlet.2024.217058_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.canlet.2020.11.019","article-title":"Epstein-Barr virus microRNAs in the pathogenesis of human cancers","volume":"499","author":"Caetano","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217058_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hon.2360","article-title":"Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer\/T-cell lymphoma: circulating EBV-miRNAs in nasal NK\/T-cell lymphoma","volume":"35","author":"Komabayashi","year":"2017","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.canlet.2024.217058_bib30","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1074\/jbc.RA118.006853","article-title":"Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer","volume":"294","author":"Wang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2024.217058_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijc.28007","article-title":"Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma","volume":"133","author":"Lei","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2024.217058_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.217058_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-020-00510-w","article-title":"METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner","volume":"53","author":"Pan","year":"2021","journal-title":"Experimental & molecular medicine"},{"key":"10.1016\/j.canlet.2024.217058_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","article-title":"Comprehensive transcriptome and mutational profiling of endemic Burkitt lymphoma reveals EBV type-specific differences","volume":"15","author":"Kaymaz","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217058_bib35","doi-asserted-by":"crossref","first-page":"15045","DOI":"10.1074\/jbc.272.24.15045","article-title":"Regulation of phosphoinositide-specific phospholipase C isozymes","volume":"272","author":"Rhee","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2024.217058_bib36","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1080\/21691401.2019.1669616","article-title":"PLCG2 promotes hepatocyte proliferation in vitro via NF-kappaB and ERK pathway by targeting bcl2, myc and ccnd1","volume":"47","author":"Ma","year":"2019","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.canlet.2024.217058_bib37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","article-title":"Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer","volume":"39","author":"Chan","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2024.217058_bib38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fgene.2020.00499","article-title":"Construction of an immunogenomic risk score for prognostication in colon cancer","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.canlet.2024.217058_bib39","article-title":"PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma","volume":"100","author":"Li","year":"2021","journal-title":"Medicine (Baltim.)"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352400452X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352400452X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:57:25Z","timestamp":1760741845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352400452X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":39,"alternative-id":["S030438352400452X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217058","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK\/T cell lymphoma growth","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217058"}}